Quality assured
Confidentiality assured
Custom research services
Rising NSI and Bloodborne Diseases Coupled with Issuance of Guidelines and ISO Standards to Complement Growth of the Safety Syringes Market
Pervasiveness of chronic diseases such as cancer and diabetes coupled with rising incidences of NSIs (Needle Stick Injuries) worldwide continues to influence the demand of safety syringes. Moreover, increasing incidences of bloodborne diseases due to inefficient needle injections has been a subject of concern among healthcare professionals, which has driven the use of delivery systems with advanced safety mechanisms.
According to WHO, around 3 million needle stick injuries were witnessed in 2003, which resulted in 37% new cases of Hepatitis B, 39% new cases of Hepatitis C and 5.5% new HIV positive cases among healthcare workers. Against this backdrop, the World Health Organization (WHO) issued new guidelines apropos to development and use of safety syringes for intradermal, subcutaneous and intramuscular injections in various healthcare settings. Various ISO standards to assure quality and safety, for instance, the Sharps Injury Protection (ISO 23908) and ISO 7886 for sterile single use syringes have also been advocated. These factors play a vital role in the development of safety syringes, consequently augmenting the growth of the safety syringes market.
Retractable Safety Syringes to Largely Contribute to the Safety Syringes Market Growth on the Back of Increased Demand of their Automatic Variant
Retractable safety syringes are poised to gain high traction in the coming years. This is mainly attributed towards encouragement provided by WHO (World Health Organization) and US OSHA (occupational Safety and Health Administration) to adopt retractable safety syringes in various healthcare settings in a bid to reduce or limit the bloodborne disease transmission. Moreover, this type of safety syringes generate less waste, offer increased safety and are easier to handle. Companies manufacturing safety syringes are focused on introducing automatic retractable safety syringes that prevent contact between soiled needle and the user, in turn providing convenience to the patient and the nurse. Safety mechanism in this retractable variant automatically retracts the needle back in the plunger post injection which offers extra protection and eliminates the risk of accidental NSI (Needle Stick Injuries). For instance, in 2020, SureSafe disposable auto-retractable safety syringe was introduced by DMC Medical for US patients, that offers enhanced patient safety and zero NSI risk. In this background, the demand for automatic retractable safety syringes is bound to increase, in turn contributing towards the valuation of the safety syringes market worldwide.
North America Likely to Ink Dominance in the Safety Syringes Market
Developed countries in North America region are poised to showcase high lucrativeness with regards to use of safety syringes. This can be attributed towards continual immunization initiatives coupled with growing incidences of chronic disorders and rising awareness regarding benefits of safety syringes and their variants over conventional syringes. In addition, the COVID 19 vaccination witnessed a momentous growth in various countries and governments have been focused on initiating vaccination drives in full swing and also involved in inking new pacts to reduce the demand and supply gap of vaccines. This has resulted in further increase in the adoption of safety syringes as a key measure to control the spread of the virus alongside transmission of other bloodborne diseases. For instance, the Government of Canada, in 2020, chalked new agreement that stressed on the establishment of adequate supply of COVID vaccines for citizens as an effort to continue with the vaccination drives. Moreover, increasing needle stick injuries in the region are also contributing to the growth of the safety syringes market. For instance, according to CDC (Centres for Disease Control and Prevention), healthcare workers in America suffer from around 600,000 to 1 million sharp and needle stick injuries each year. Alongside these facts, other macro level factors such as established healthcare infrastructure and increasing GDP per capita continue to elevate the potential of the region as a major user of medical equipment, in turn complementing the growth of the safety syringes market.
Safety Syringes Market Competitive Landscape
Key players operating in the safety syringes market continue to focus on development and large scale distribution of enhanced products to ensure adequate supply of along with high patient and user safety. For instance, in 2021, Roncadelle Operations and Datwyler collaborated to develop advanced safety syringes. Datwyler supported Roncadelle in developing Safer – a line of automatic retractable safety syringes that prevent the re-use of the safety syringe, in turn facilitating infection control. Safer’s commercial production will start in 2022 in Italy with CE mark certification expected in the same year. Likewise, same year, West Pharmaceutical Services Inc. partnered with Venus Remedies Ltd., to develop and launch NovaGuard SA safety syringes in India. In 2022, Credence MedSystems and SCHOTT collaborated to develop integrated PFS system and introduce The Companion safety syringes that feature advanced safety and usability.
Few of the key players in the safety syringes market include Boston Scientific Corporation, Medtronic, B. Braun Holding GmbH & Co. Kg., Becton Dickinson, Smiths Medical, Unilife, Cardinal Health and QuVa Pharmacy.
The Global Safety Syringes Market Is Segmented As Below:
By Technology
By Therapy
By End User
By Region
Key Elements Included In The Study: Global Safety Syringes Market
Post Sale Support, Research Updates & Offerings
We value the trust shown by our customers in Fairfield Market Research. We support our clients through our post sale support, research updates and offerings.
Disclaimer:
Considering the volatility of business today, traditional approaches to strategizing a game plan can be unfruitful if not detrimental. True ambiguity is no way to determine a forecast. A myriad of predetermined factors must be accounted for such as the degree of risk involved, the magnitude of circumstances, as well as conditions or consequences that are not known or unpredictable. To circumvent binary views that cast uncertainty, the application of market research intelligence to strategically posture, move, and enable actionable outcomes is necessary.
View Methodology
Quality assured
Confidentiality assured
Custom research services
